Surgery coordination
Lumpectomy or mastectomy plans are reviewed alongside systemic therapy timing — before or after surgery when needed.
7 min read
Breast cancer treatment depends on the type of tumour, stage, hormone and HER2 status, and your overall health. Dr. (Brig.) A. K. Dhar helps you understand reports, compare options, and plan systemic care with calm, clear guidance.

Breast cancer occurs when cells in the breast grow abnormally and form a tumour. It can affect both women and men, though it is far more common in women. Most cases begin in the milk ducts (ductal carcinoma) or milk-producing glands (lobular carcinoma).
Care is personalised. Hormone receptor status, HER2 status, staging, and your preferences all shape whether surgery, chemotherapy, hormone therapy, targeted therapy, immunotherapy, or a combination is recommended.
The goal is not only tumour control — it is a plan you understand, with support for side effects, follow-up, and questions that arise along the way.
Not every lump is cancer, but any new change deserves review.
Screening mammograms can find cancers before symptoms appear. Discuss screening timing with your doctor based on age and risk.
Diagnosis usually combines clinical exam with imaging and biopsy.
This checklist helps organise your concerns. It does not replace a consultation.
Select anything that applies — then book a visit to review reports together.
Book appointmentOptions depend on stage, biology, and your goals. Many people receive more than one modality over time.
Lumpectomy or mastectomy plans are reviewed alongside systemic therapy timing — before or after surgery when needed.
Used when cancer biology or stage suggests benefit, with clear explanation of schedule, side effects, and supportive care.
For hormone-receptor-positive disease — oral or injectable options that reduce recurrence risk over years.
HER2-directed drugs and selected immunotherapy where evidence supports their use for your tumour type.
Pathology, imaging, and prior opinions are reviewed so the conversation starts with clear facts.
No. Many lumps are benign. Imaging and, when needed, biopsy clarify the cause. Any new lump should still be checked promptly.
Not always. Decisions depend on stage, tumour biology, lymph node status, and genomic tests in selected cases. Some patients do well with surgery and hormone therapy alone.
HER2-positive tumours overexpress a protein that can drive growth. Targeted HER2 therapies are often part of treatment and have improved outcomes significantly.
Yes, though it is uncommon. Men with a breast lump, nipple change, or family history should seek the same careful evaluation.
Whenever you want more confidence before major decisions — after diagnosis, before surgery, or when comparing systemic options. Bringing full reports helps the review.
Share a few details and the clinic team will help arrange a consultation with Dr. Dhar. Prefer to talk now? Reach the appointment desk directly.